| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1094 |
0-288 |
Sentence |
denotes |
With no access to requisite information on the structure and life cycle of the novel Coronavirus, research and development programs on therapeutic agents become a far‐fetched milestone, rendering the tried‐and‐true primary prevention measures the only proper means to confront SARS‐CoV‐2. |
| T1095 |
289-418 |
Sentence |
denotes |
As of today, few existing drugs have been considered for treatment of COVID‐19, with scant reports on benevolence of the results. |
| T1096 |
419-621 |
Sentence |
denotes |
As our meager knowledge of SARS‐CoV‐2 is advancing, one may speculate the advent of an effectual vaccine, alongside treatment options that might include antiviral agents, and even monoclonal antibodies. |
| T1097 |
622-862 |
Sentence |
denotes |
At the time of writing this manuscript, no definitive treatment option has been known for COVID‐19; however, the unabating flow of investigations and clinical trials may soon lead us to the optimal therapy for COVID‐19‐associated pneumonia. |
